Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseases
Giulio Cavalli(Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele), Charles A. Dinarello(University of Colorado Health), Massimo Imazio, Maria Cristina Maggio(Hospital Universitario Santa Cristina), Giacomo Emmi(Azienda Ospedaliero-Universitaria Careggi), Giuseppe Lopalco(University of Bari Aldo Moro), Jurgen Sota(University of Siena), Serena Colafrancesco(Sapienza University of Rome)
Cited by 330
Related Papers
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2021|1.1k
Differential requirement for the activation of the inflammasome for processing and release of IL-1β in monocytes and macrophages
|Blood|2008|777
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis
|Frontiers in Pharmacology|2019|616
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
|Proceedings of the National Academy of Sciences|2018|556